Ionis Pharmaceuticals (IONS) Revenue by Product

History

Date	Spinraza	Wainua	Tegsedi and Waylivra
Sep 30, 2025	222.35M	42.79M	35.25M
Jun 30, 2025	223.56M	35.16M	36.17M
Mar 31, 2025	225.96M	28.52M	30.83M
Dec 31, 2024	216.41M	20.28M	33.74M
Sep 30, 2024	214.41M	-	34.74M
Jun 30, 2024	224.45M	-	34.11M
Mar 31, 2024	228.72M	-	36.57M
Dec 31, 2023	240.51M	-	34.42M
Sep 30, 2023	245.51M	-	32.42M
Jun 30, 2023	239.91M	-	30.05M
Mar 31, 2023	238.52M	-	29.78M
Dec 31, 2022	242.09M	-	29.47M
Sep 30, 2022	244.09M	-	31.47M
Jun 30, 2022	249.02M	-	41.07M
Mar 31, 2022	261.56M	-	42.22M
Dec 31, 2021	267.73M	-	55.90M
Sep 30, 2021	273.73M	-	65.90M
Jun 30, 2021	281.15M	-	69.38M
Mar 31, 2021	280.99M	-	73.84M
Dec 31, 2020	287.00M	-	69.00M

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.